Special indications for gelatin plasma substitutes in gynecology.
D000031:Abortion, Septic / Q000150:complications*; D001778:Blood Coagulation Disorders / Q000209:etiology; D004619:Embolism, Amniotic Fluid; D005260:Female; D005313:Fetal Death; D005342:Fibrinolysis; D005780:Gelatin; D006474:Hemorrhagic Disorders / Q000628:therapy*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010920:Placenta; D010922:Placenta Diseases; D010952:Plasma Substitutes; D011247:Pregnancy; D011248:Pregnancy Complications; D011655:Pulmonary Embolism / Q000628:therapy; D012771:Shock, Hemorrhagic / Q000628:therapy; D012772:Shock, Septic / Q000209:etiology / Q000628:therapy; D013300:Streptokinase / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000628:therapy*; D013925:Thromboplastin; D013927:Thrombosis / Q000628:therapy
D010952:Plasma Substitutes; D005780:Gelatin; D013925:Thromboplastin; D013300:Streptokinase